Previous animal research has suggested that certain clinical manifestations of MPS IIIB may be partially caused by overactivation of the TLR-4 cascade [17], largely driven by the PAMP/DAMP recognition of GAGs, such as heparan sulfate. Here, TLR4 is linked to mucopolysaccharidosis type 3B.